Max Planck Society, Vaxxilon deal

Max Planck and Actelion Ltd. (SIX:ATLN, Allschwil, Switzerland) launched Vaxxilon. The company has exclusive, worldwide rights to multiple preclinical vaccine candidates targeting undisclosed bacteri...